Design Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 6 published signal records.
Design Therapeutics last closed at $11.65 (+1.39%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -10.3×. Its overall grade ranks 177 of 736 stocks in Healthcare.
About this company
Design Therapeutics last closed at $11.65 (+1.39%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 177/736
Valuation grade A
Related stocks
- Ionis PharmaceuticalsCompetitor
핵산 기반 유전질환 치료제 개발 경쟁사
- Avidity BiosciencesCompetitor
유전성 근육질환·RNA 치료제 분야 경쟁사
- Sarepta TherapeuticsCompetitor
유전성 근육질환 치료제 개발 경쟁사
About Design Therapeutics
- What technical signals does Design Therapeutics (DSGN) have?
- Design Therapeutics current technical signals: no active technical signal.
- Is Design Therapeutics a cup-and-handle pattern?
- No. Design Therapeutics has no valid Cup signal right now.
- What published figures are available for Design Therapeutics?
- Market cap: $663.63M. Trailing 12 months PER: -10.3×. Latest quarter PBR: 3.61×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Design Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.